AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Amphastar Pharmaceuticals, Inc.

$27.72 +$1.26 (+4.76%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$26.93
Day Range
$26.76$27.79
Year Range
$16.65$29.52
Market Cap
1.18B
AVG Volume
454.21K
Trailing/Forward PE
15.93/8.74
PEG ratio
-1.15
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AMPH Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2730.02M
26 Q1720.53M
25 Q4719.89M
25 Q3723.3M
25 Q2720.28M
25 Q1728.26M
24 Q4729.57M
24 Q3721.15M
24 Q2712.89M
24 Q1676.21M
Net Income (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AMPH Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q278.55M
26 Q179.23M
25 Q498.09M
25 Q3111.63M
25 Q2134.71M
25 Q1141.63M
24 Q4159.52M
24 Q3157.72M
24 Q2166.51M
24 Q1154.69M
Operating Income (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AMPH Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2114.28M
26 Q1116.74M
25 Q4140.4M
25 Q3149.94M
25 Q2181.67M
25 Q1194.7M
24 Q4205.42M
24 Q3214.25M
24 Q2229.88M
24 Q1211.56M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: AMPH

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Amphastar Pharmaceuticals, Inc.
AMPH
Stockpicker

Video analysis: AMPH

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: AMPH

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.